Sector
PharmaceuticalsOpen
₹5,874Prev. Close
₹5,855.5Turnover(Lac.)
₹308.42Day's High
₹5,943.5Day's Low
₹5,852.552 Week's High
₹6,175.552 Week's Low
₹4,863Book Value
₹465.47Face Value
₹10Mkt Cap (₹ Cr.)
9,828.49P/E
37.8EPS
156.67Divi. Yield
4.39Y/e 31 Mar( In .Cr) | Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 |
---|---|---|---|---|
Equity Capital | 16.6 | 16.6 | 16.6 | 16.6 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 521.64 | 734.29 | 599.89 | 687.11 |
Net Worth | 538.24 | 750.89 | 616.49 | 703.71 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Jun-2021 | Jun-2020 | Dec-2017 | Dec-2016 |
---|---|---|---|---|
Revenue | 1,008.73 | 1,355.86 | 1,103.96 | 992.56 |
yoy growth (%) | -25.6 | 22.81 | 11.22 | 5.64 |
Raw materials | -314.82 | -431.44 | -441.09 | -411.54 |
As % of sales | 31.2 | 31.82 | 39.95 | 41.46 |
Employee costs | -150.47 | -182.93 | -169.64 | -154.23 |
Y/e 31 Mar( In .Cr) | Jun-2021 | Jun-2020 | Dec-2017 | Dec-2016 |
---|---|---|---|---|
Profit before tax | 233.28 | 354.85 | 135.19 | 115.17 |
Depreciation | -30.04 | -29.45 | -26.4 | -24.81 |
Tax paid | -56.48 | -100.77 | -58.28 | -36.04 |
Working capital | -233.3 | 269.12 | 35.2 | 57.07 |
Other operating items |
Y/e 31 Mar | Jun-2021 | Jun-2020 | Dec-2017 | Dec-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -25.6 | 22.81 | 11.22 | 5.64 |
Op profit growth | -21.99 | 129.18 | 19.07 | 38.5 |
EBIT growth | -34.03 | 162.48 | 17.38 | 38.2 |
Net profit growth | -30.41 | 170.55 | 18.67 | 47.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
S N Talwar
Independent Director
Rani A Jadhav
Managing Director
Milind Thatte
Non Executive Director
Aalok Agrawal
Company Sec. & Compli. Officer
Zeal Shah
Chairperson
S Madhavan
Executive Director
Lokesh Chandak
Non Executive Director
Seema Sambasivan
Godrej One 8th Floor,
Projshanagar Vikhroli (East),
Maharashtra - 400079
Tel: 91-22-62109000
Website: http://www.pghealthindia.com
Email: investorgrievance.im@pg.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in year 1967. The Companys name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002. Late...
Read More
Reports by Procter & Gamble Health Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.